FindTrial
Sign In

Transarterial Radioembolization

PROCEDURE7 trials

Sponsors

King Faisal Specialist Hospital & Research Center, Nemours Children's Clinic, Abramson Cancer Center at Penn Medicine, University of Chicago, University Hospital of Patras

Conditions

Anatomic Stage IV Breast Cancer AJCC v8Early StageForegut Carcinoid TumorGI CancerGI CarcinomaGallbladder AdenocarcinomaGastric AdenocarcinomaHepatoblastoma

Phase 2

CapTemY90 for Grade 2/3 NET Liver Metastases
RecruitingNCT04339036
Abramson Cancer Center at Penn MedicineNeuroendocrine Tumor Grade 2, Neuroendocrine Tumors
Start: 2021-10-07End: 2026-05-01Target: 70Updated: 2025-12-10
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
WithdrawnNCT04931420
University of ChicagoForegut Carcinoid Tumor, Gallbladder Adenocarcinoma, Gastric Adenocarcinoma +5
Start: 2022-05-19End: 2027-11-01Updated: 2024-07-31
Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer
RecruitingNCT06860815
City of Hope Medical CenterAnatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Carcinoma in the Liver
Start: 2026-04-01End: 2027-01-30Target: 11Updated: 2026-01-28

Phase 4

Transarterial Radioembolization Versus Chemoembolization for the Treatment of Hepatocellular Carcinoma
NCT02729506
King Faisal Specialist Hospital & Research CenterHepatocellular Carcinoma
Start: 2016-01-31End: 2017-12-31Target: 150Updated: 2016-04-06

Unknown Phase

Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors
TerminatedNCT04315883
Nemours Children's ClinicHepatoblastoma, Hepatocellular Carcinoma, Liver Tumors +3
Start: 2021-02-11End: 2024-03-28Updated: 2024-06-12
The AMARA (As Much As Reasonably Achievable) Study
RecruitingNCT06257030
University Hospital of PatrasLiver Cancer
Start: 2024-02-05End: 2027-02-05Target: 100Updated: 2024-04-24
A Prospective Observational Study on Efficacy of TARE for Early Stage HCC
Active, not recruitingNCT07278102
Seoul National University HospitalEarly Stage, Hepatocellular Carcinoma (HCC), Radioembolization
Start: 2022-03-28End: 2026-05-31Target: 200Updated: 2025-12-11

Related Papers

TARE-Y90 for Primary Malignant Liver Tumors in Pediatric Patients
Oncology Times2022-10-31
ArTisaN trial protocol: a single Centre, open-label, phase II trial of the safety and efficacy of TheraSphere selective internal radiation therapy (SIRT) in the treatment of inoperable metastatic (liver) neuroendocrine neoplasia (NENs).
2022-07-201 citations